Avinger Stock Price, News & Analysis (NASDAQ:AVGR) $3.38 +0.47 (+16.15%) (As of 12/4/2023 ET) Add Compare Share Share Today's Range$2.90▼$3.4950-Day Range$2.85▼$7.6152-Week Range$2.78▼$24.30Volume117,770 shsAverage Volume541,425 shsMarket Capitalization$4.63 millionP/E RatioN/ADividend YieldN/APrice Target$5.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Avinger MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside47.9% Upside$5.00 Price TargetShort InterestHealthy0.37% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.85Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($3.59) to ($2.26) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.36 out of 5 stars 3.5 Analyst's Opinion Consensus RatingAvinger has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $5.00, Avinger has a forecasted upside of 47.9% from its current price of $3.38.Amount of Analyst CoverageAvinger has only been the subject of 1 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.37% of the float of Avinger has been sold short.Short Interest Ratio / Days to CoverAvinger has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Avinger has recently decreased by 70.39%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAvinger does not currently pay a dividend.Dividend GrowthAvinger does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AVGR. Previous Next 3.3 News and Social Media Coverage News SentimentAvinger has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Avinger this week, compared to 1 article on an average week.Search Interest3 people have searched for AVGR on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Avinger insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.29% of the stock of Avinger is held by insiders.Percentage Held by InstitutionsOnly 8.14% of the stock of Avinger is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Avinger are expected to grow in the coming year, from ($3.59) to ($2.26) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Avinger is -0.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avinger is -0.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAvinger has a P/B Ratio of 0.40. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Avinger Stock (NASDAQ:AVGR)Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is headquartered in Redwood City, California.Read More AVGR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AVGR Stock News HeadlinesDecember 1, 2023 | benzinga.comAvinger Stock (NASDAQ:AVGR) Dividends: History, Yield and DatesOctober 27, 2023 | finance.yahoo.comAvinger, Inc. (NASDAQ:AVGR) Q3 2023 Earnings Call TranscriptDecember 5, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.October 26, 2023 | finanznachrichten.deAvinger, Inc.: Avinger Reports Third Quarter 2023 ResultsOctober 26, 2023 | finance.yahoo.comAvinger Reports Third Quarter 2023 ResultsOctober 26, 2023 | finance.yahoo.comAvinger (AVGR) Reports Q3 Loss, Lags Revenue EstimatesOctober 25, 2023 | benzinga.comAvinger Earnings PreviewOctober 19, 2023 | finance.yahoo.comAvinger to Announce Third Quarter 2023 Results on October 26December 5, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.September 27, 2023 | finanznachrichten.deAvinger, Inc.: Avinger Raises $5.3 Million via At-The-Market FacilitySeptember 27, 2023 | finance.yahoo.comAvinger Raises $5.3 Million via At-The-Market FacilitySeptember 21, 2023 | benzinga.comThinking about buying stock in Neptune Wellness Solutions, Kezar Life Sciences, Avinger, Canopy Growth Corp, or Nio Inc?September 20, 2023 | finanznachrichten.deAvinger, Inc.: Avinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing DeviceSeptember 20, 2023 | benzinga.comWhat's Going On With Avinger Inc. Stock Today?September 19, 2023 | seekingalpha.comAvinger jumps 28%, enters ATM equity offeringSeptember 19, 2023 | benzinga.comAvinger Stock Is Soaring Again: What's Going On?September 19, 2023 | benzinga.comNio, PayPal, Block, Tesla, Avinger: What You Need To Know About These Five Stocks Trending TodaySeptember 18, 2023 | marketwatch.comAvinger Shares Rise 64% After Commercial Launch of Tigereye STSeptember 18, 2023 | msn.comWhy Is MedTech Firm Avinger Stock Trading Higher Today?September 18, 2023 | finance.yahoo.comAvinger Initiates Full Commercial Launch of Tigereye ST Image-Guided CTO Crossing DeviceAugust 26, 2023 | money.usnews.comAvinger IncAugust 25, 2023 | finance.yahoo.comUnmasking the Value Trap: A Deep Dive into Avinger Inc (AVGR)August 24, 2023 | finance.yahoo.comAvinger Announces Presentations by Key Opinion Leaders at AMP (The Amputation Prevention Symposium) 2023August 4, 2023 | finance.yahoo.comAvinger Announces Conversion of 12% of CRG Term Debt into EquityJuly 28, 2023 | msn.comAvinger GAAP EPS of -$0.59 misses by $0.10, revenue of $2.04M misses by $0.26MJuly 28, 2023 | markets.businessinsider.comAvinger (AVGR) Receives a Buy from H.C. WainwrightJuly 28, 2023 | finance.yahoo.comAvinger Reports Second Quarter 2023 ResultsSee More Headlines Receive AVGR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/26/2023Today12/04/2023Fiscal Year End12/31/2023Next Earnings (Estimated)3/20/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AVGR CUSIPN/A CIK1506928 Webwww.avinger.com Phone(650) 241-7900Fax800-229-2696Employees71Year FoundedN/APrice Target and Rating Average Stock Price Target$5.00 High Stock Price Target$5.00 Low Stock Price Target$5.00 Potential Upside/Downside+47.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($32.9056) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-17,620,000.00 Net Margins-225.61% Pretax Margin-225.61% Return on Equity-6,767.92% Return on Assets-87.99% Debt Debt-to-Equity RatioN/A Current Ratio0.85 Quick Ratio0.55 Sales & Book Value Annual Sales$8.27 million Price / Sales0.56 Cash FlowN/A Price / Cash FlowN/A Book Value$8.36 per share Price / Book0.40Miscellaneous Outstanding Shares1,370,000Free Float1,311,000Market Cap$4.63 million OptionableNot Optionable Beta1.30 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Jeffrey M. Soinski (Age 61)President, CEO & Director Comp: $605.15kMr. Nabeel P. Subainati (Age 39)VP of Finance, Principal Financial Officer & Accounting Officer Comp: $295.85kMr. Himanshu N. Patel (Age 63)Chief Technology Officer Comp: $423.09kMr. Keith SchaeferChief Operating OfficerKey CompetitorsGBSNYSE:GBSQuoin PharmaceuticalsNASDAQ:QNRXBluejay DiagnosticsNASDAQ:BJDXINVO BioscienceNASDAQ:INVOGlucoTrackNASDAQ:GCTKView All CompetitorsInsiders & InstitutionsProsperity Wealth Management Inc.Bought 67,550 shares on 9/12/2023Ownership: 0.628%Nabeel Paul SubainatiSold 14 sharesTotal: $170.10 ($12.15/share)View All Insider TransactionsView All Institutional Transactions AVGR Stock Analysis - Frequently Asked Questions Should I buy or sell Avinger stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" AVGR shares. View AVGR analyst ratings or view top-rated stocks. What is Avinger's stock price target for 2024? 1 brokers have issued twelve-month price objectives for Avinger's stock. Their AVGR share price targets range from $5.00 to $5.00. On average, they expect the company's stock price to reach $5.00 in the next twelve months. This suggests a possible upside of 47.9% from the stock's current price. View analysts price targets for AVGR or view top-rated stocks among Wall Street analysts. How have AVGR shares performed in 2023? Avinger's stock was trading at $16.2750 at the beginning of 2023. Since then, AVGR stock has decreased by 79.2% and is now trading at $3.38. View the best growth stocks for 2023 here. Are investors shorting Avinger? Avinger saw a decline in short interest during the month of November. As of November 15th, there was short interest totaling 4,500 shares, a decline of 70.4% from the October 31st total of 15,200 shares. Based on an average trading volume of 1,910,000 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.4% of the shares of the company are short sold. View Avinger's Short Interest. When is Avinger's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 20th 2024. View our AVGR earnings forecast. How were Avinger's earnings last quarter? Avinger, Inc. (NASDAQ:AVGR) issued its quarterly earnings data on Thursday, October, 26th. The medical device company reported ($2.92) earnings per share for the quarter, missing analysts' consensus estimates of ($2.85) by $0.07. The medical device company earned $1.82 million during the quarter, compared to the consensus estimate of $2.40 million. Avinger had a negative trailing twelve-month return on equity of 6,767.92% and a negative net margin of 225.61%. When did Avinger's stock split? Shares of Avinger reverse split on the morning of Wednesday, September 13th 2023. The 1-15 reverse split was announced on Wednesday, September 13th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, September 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. What other stocks do shareholders of Avinger own? Based on aggregate information from My MarketBeat watchlists, some companies that other Avinger investors own include Bionano Genomics (BNGO), Novan (NOVN), Titan Pharmaceuticals (TTNP), Matinas BioPharma (MTNB), Zosano Pharma (ZSAN), Organigram (OGI), Onconova Therapeutics (ONTX), ADMA Biologics (ADMA), Aeterna Zentaris (AEZS) and Actinium Pharmaceuticals (ATNM). When did Avinger IPO? (AVGR) raised $60 million in an initial public offering (IPO) on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers. How do I buy shares of Avinger? Shares of AVGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:AVGR) was last updated on 12/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avinger, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.